BI 706321

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 706321, covering 2025-08-24 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated [Phase 1]